Clinical Trials
20 trialsNCT03910660 2026-05-15
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
Phase 1/2 Completed
NCT02750371 2026-05-14
ISOMAB
University Hospital, Bordeaux
Phase NA Completed
NCT04727723 2026-05-04
REAL-LU
Novartis
Completed
NCT00001452 2026-05-01
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
National Institutes of Health Clinical Center (CC)
Completed
NCT01744249 2026-04-28
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Grupo Espanol de Tumores Neuroendocrinos
Phase 2/3 Completed
NCT05078853 2026-04-24
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
Soroka University Medical Center
Completed
NCT07247526 2026-04-21
Effect of Foot Bath on Anxiety and Physiological Parameters
Trakya University
Phase NA Completed
NCT05927623 2026-04-20
MisterFIt
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Completed
NCT04375267 2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1 Completed
NCT06629220 2026-04-14
Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior
University Ghent
Phase NA Completed
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT05631795 2026-04-07
ALPINIST
Novartis
Phase 4 Completed
NCT04069299 2026-03-31
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT06826170 2026-03-30
HYPOADENO
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase NA Completed
NCT00005927 2026-03-24
Study of Adrenal Gland Tumors
National Institutes of Health Clinical Center (CC)
Completed
NCT04074642 2026-03-24
FIRST
Centre Hospitalier Universitaire de Nice
Phase NA Completed
NCT03244956 2026-03-23
MERAIODE
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed
NCT05361668 2026-03-19
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Phase 2 Completed
NCT02402920 2026-03-10
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed